Detalles de la búsqueda
1.
Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.
Biol Blood Marrow Transplant
; 26(8): e198-e201, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32304873
2.
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(10): 1993-2001, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31229641
3.
BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(6): 1107-1115, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30716453
4.
Dupilumab for refractory sclerotic-type cutaneous graft-versus-host disease.
J Eur Acad Dermatol Venereol
; 37(11): e1323-e1324, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37416952
5.
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 22(4): 658-668, 2016 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26743340
6.
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).
Biol Blood Marrow Transplant
; 22(1): 71-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26256940
7.
Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphoma.
Am J Hematol
; 89(1): 19-24, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23959599
8.
Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II study.
Support Care Cancer
; 22(11): 2911-6, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24838259
9.
Impact of chronic graft-versus-host disease on non-relapse mortality and survival.
Leuk Lymphoma
; : 1-8, 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38865104
10.
Bone Marrow Harvest: A White Paper of Best Practices by the NMDP Marrow Alliance.
Transplant Cell Ther
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38642840
11.
Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents.
Cancer Med
; 12(7): 8228-8237, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653918
12.
Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma.
Transplant Cell Ther
; 28(6): 342.e1-342.e5, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35248778
13.
Impact of Race and Geographic Area of Residence on Outcomes After Allogeneic Stem Cell Transplant.
Front Oncol
; 12: 801879, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35280722
14.
Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults.
Blood Adv
; 6(4): 1342-1349, 2022 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932790
15.
Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience.
Cancers (Basel)
; 14(22)2022 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36428678
16.
Erratum to "Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease" [Biol Blood Marrow Transplant 22(2016):658-668].
Biol Blood Marrow Transplant
; 22(7): 1341, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27291293
17.
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.
Hematol Oncol
; 29(4): 202-10, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21360728
18.
Cytopenias After CD19 Chimeric Antigen Receptor T-Cells (CAR-T) Therapy for Diffuse Large B-Cell Lymphomas or Transformed Follicular Lymphoma: A Single Institution Experience.
Cancer Manag Res
; 13: 8901-8906, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34876852
19.
Safety of Axicabtagene Ciloleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
; 21(4): 238-245, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33132101
20.
Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS.
Leuk Lymphoma
; 62(4): 944-951, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33231122